inhalation profiles
Showing 1 - 25 of 4,397
Asthma Trial in Tampere (Buventol® Easyhaler® 200 µg/inhalation dmDPI, Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI,
Recruiting
- Asthma
- Buventol® Easyhaler® 200 µg/inhalation dmDPI
- +2 more
-
Tampere, FinlandTampere University Hospital
Oct 26, 2022
Healthy Trial in Mount Royal (Niclosamide Inhalation Powder, Placebo)
Completed
- Healthy
- Niclosamide Inhalation Powder
- Placebo
-
Mount Royal, Quebec, CanadaAltasciences
Feb 1, 2022
Breathing Parameter Measurements for Lung Deposition Simulation
Recruiting
- Asthma
- COPD
- Emptied dry powder inhalers (DPI) used in routine asthma and COPD therapy
-
Debrecen, Hungary
- +2 more
Nov 29, 2022
Asthma Trial in Brisbane (Voriconazole Inhalation Powder, Placebo)
Completed
- Asthma
- Voriconazole Inhalation Powder
- Placebo
-
Brisbane, Queensland, AustraliaQ-Pharm Pty Ltd (Nucleus Networks)
Nov 17, 2021
Normal Healthy Volunteers Without Chronic Medical Conditions, Coronary Artery Disease, Cardiac Risk Factors Trial in New Orleans
Completed
- Normal Healthy Volunteers Without Chronic Medical Conditions
- +3 more
- Slow Infusion of Rubidium-82
-
New Orleans, LouisianaOchsner
Jan 16, 2023
Healthy Trial in Mississauga (Voriconazole Inhalation Powder, Placebo)
Completed
- Healthy
- Voriconazole Inhalation Powder
- Placebo
-
Mississauga, Ontario, CanadaCliantha Research
May 3, 2021
Safety and Tolerability Trial in Cypress (inhaled human insulin, Insulin Lispro (Humalog U-100))
Terminated
- Safety and Tolerability
- inhaled human insulin
- Insulin Lispro (Humalog U-100)
-
Cypress, CaliforniaWCCT
Sep 11, 2019
COVID-19 Trial in Beijing, Shanghai (Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg), Placebo)
Completed
- COVID-19
- Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg)
- Placebo
-
Beijing, China
- +1 more
Jul 14, 2022
Pulmonary Embolism, Venous Thromboembolism, Metabolomics Trial in Boston (Oxygen Therapy, Non-rebreather mask)
Not yet recruiting
- Pulmonary Embolism
- +3 more
- Oxygen Therapy
- Non-rebreather mask
-
Boston, MassachusettsMassachusetts General Hospital
May 26, 2023
Healthy Volunteer Trial in Prahran (Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI),
Completed
- Healthy Volunteer
- Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
- Vardenafil Oral Tablet
-
Prahran, Victoria, AustraliaNucleus Network, Burnet Institute
Nov 2, 2022
COPD Trial in Brooklyn (Treatment A (BGF MDI HFO with oral activated charcoal), Treatment B (BGF MDI HFA with oral activated
Recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A (BGF MDI HFO with oral activated charcoal)
- Treatment B (BGF MDI HFA with oral activated charcoal)
-
Brooklyn, MarylandResearch Site
Aug 11, 2022
Leukemia Trial in Alexandria (Peppermint Inhalation, Swedish Massage)
Completed
- Leukemia
- Peppermint Inhalation
- Swedish Massage
-
Alexandria, EgyptEman Arafa Badr
Oct 17, 2023
Age-associated Memory Impairment Trial in Novi Sad (Supplement, Placebo)
Recruiting
- Age-associated Memory Impairment
- Supplement
- Placebo
-
Novi Sad, Vojvodina, SerbiaFSPE Applied Bioenergetics Lab
Jun 8, 2023
Asthma Trial in Huntington Beach, Raleigh, San Antonio (Fluticasone Propionate MDPI, Fluticasone Propionate/Salmeterol MDPI,
Completed
- Asthma
- Fluticasone Propionate MDPI
- +2 more
-
Huntington Beach, California
- +2 more
Nov 5, 2021
Inhalation Injury Trial in Giza (Pilates exercises, Conventional physical therapy exercise program)
Recruiting
- Inhalation Injury
- Pilates exercises
- Conventional physical therapy exercise program
-
Giza, EgyptFaculty of Physical Therapy
Aug 14, 2023
COVID-19 Trial (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant COVID-19 vaccine (adenovirus type
Not yet recruiting
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
- Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH)
- (no location specified)
Jan 11, 2022
COPD Trial in India, United States (Test Product - Tiotropium Bromide Inhalation Powder 18 mcg, Spiriva Handihaler (Tiotropium
Active, not recruiting
- COPD
- Test Product - Tiotropium Bromide Inhalation Powder 18 mcg
- +2 more
-
Los Angeles, California
- +32 more
Aug 3, 2023
Intermittent Explosive Disorder Trial in Columbus (Nitrous oxide, Room Air)
Recruiting
- Intermittent Explosive Disorder
- Nitrous oxide
- Room Air
-
Columbus, OhioOhio State University Wexner Medical Center
Nov 1, 2023
COPD Trial (HRS-9821)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- (no location specified)
Nov 14, 2022
Long COVID-19 Syndrome Trial in Shenzhen (MSC-derived exosomes)
Recruiting
- Long COVID-19 Syndrome
- MSC-derived exosomes
-
Shenzhen, Guangdong, ChinaHuazhong University of Science and Technology Union Shenzhen Hos
Apr 12, 2023
Hemodynamic Trial in Jiaxing
Recruiting
- Hemodynamic
-
Jiaxing, Zhejiang, ChinaAffiliated Hospital of Jiaxing University
Nov 1, 2023
Dysmenorrhea Trial in Sakarya (Lavender oil inhalation, Placebo)
Recruiting
- Dysmenorrhea
- Lavender oil inhalation
- Placebo
-
Sakarya, TurkeySakarya Training and Research Hospital
Aug 12, 2023
Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 500/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 29, 2023
Pharmacokinetics of Procaterol in Elite Athletes
Completed
- Asthma
-
Copenhagen, DenmarkBispebjerg Hospital
Feb 27, 2023
Atelectasis After Inhalation or Intravenous Induction in
Recruiting
- Atelectasis
- Pediatric Anesthesia
- Type of anesthesia induction
-
Milan, ItalyVittore Buzzi Children's Hospital
Oct 4, 2023